About TB drug
TB drug is a Healthcare company based in Orlando (United States) founded in 2000. Coordinates global TB drug research, development, trials, and stakeholder collaboration to fight tuberculosis. It operates on a B2B model. TB drug offers products and services including TB Drug Pipeline and Annual Survey. Its focus areas include Infectious Diseases, Tuberculosis, Drug Development and Public Health. Its competitors include Pfizer, LabConnect and Evergreen Theragnostics; 3 of its 3 listed competitors have raised funding.
Company details
The Working Group for New TB Drugs is a network under the Stop TB Partnership that guides and accelerates the development of new tuberculosis therapies worldwide. It conducts surveys, tracks drug pipelines, organizes meetings, and fosters collaboration among researchers, funders, and policymakers. Based in New York, NY, it focuses on creating shorter, more effective regimens to improve treatment adherence and reduce costs, while addressing drug-resistant strains and pediatric needs.
- Headquarters Orlando, United States
- SectorsHealthcare
- Website newtbdrugs.org
- Social X Facebook
Products & Services of TB drug
TB drug offers a comprehensive portfolio of products and services, including TB Drug Pipeline and Annual Survey.
Interactive tool for tracking TB drug candidates and clinical trials globally
Survey on global TB drugs pipeline to enhance research coordination
Competitors of TB drug
TB drug has 3 listed competitors in our database, 3 of them funded. They include Pfizer, LabConnect and Evergreen Theragnostics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pfizer.com | 1849 | New York, United States | $8M | Pharmaceutical products for treating multiple diseases are provided. | ||
| labconnect.com | 2002 | Johnson, United States | $28.5M | Laboratory testing, clinical trial research, and biopharma services are provided. | ||
| evergreentgn.com | 2019 | Jersey, United States | $75.91M | Radiopharmaceutical manufacturing and regulatory services are provided. |
Detailed competitors of TB drug
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of TB drug
Websites that share an audience with TB drug (newtbdrugs.org).
Websites whose visitors overlap most with TB drug. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dndi.org | 66% | 60K | #612,800 | View details | |
| biolinerx.com | 62% | 5.1K | #4,098,574 | View details | |
| iris-pharma.com | 58% | 2.2K | #10,426,473 | View details |
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as TB drug (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 5.33 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about TB drug
TB drug was founded in 2000.
TB drug is headquartered in Orlando, United States. It is registered at Orlando, Florida, United States.
The Working Group for New TB Drugs is a network under the Stop TB Partnership that guides and accelerates the development of new tuberculosis therapies worldwide. It conducts surveys, tracks drug pipelines, organizes meetings, and fosters collaboration among researchers, funders, and policymakers. Based in New York, NY, it focuses on creating shorter, more effective regimens to improve treatment adherence and reduce costs, while addressing drug-resistant strains and pediatric needs.
TB drug's top competitors include Pfizer, LabConnect and Evergreen Theragnostics.
TB drug offers TB Drug Pipeline and Annual Survey.